In contrast to the previously published study using PEA for biomarker identification of PD and APD [11], we did not find significantly different levels of FGF-5, VEGF-A and FGF-19 in PD versus MSA, despite observing a similar trend, i.e. higher expression levels in PD than in MSA. This evidence concerns the gene FGF19 and multiple system atrophy.